A phase I randomized dose-seeking trial of PCK3145 in asymptomatic, castrate metastatic prostate cancer patients

Trial Profile

A phase I randomized dose-seeking trial of PCK3145 in asymptomatic, castrate metastatic prostate cancer patients

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 11 Jun 2008

At a glance

  • Drugs Tigapotide (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 11 Jun 2008 The expected completion date for this trial is 1 Mar 2009 as reported by ClinicalTrials.gov.
    • 01 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top